Correlation Between Genmab AS and SP Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and SP Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and SP Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and SP Group AS, you can compare the effects of market volatilities on Genmab AS and SP Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of SP Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and SP Group.

Diversification Opportunities for Genmab AS and SP Group

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Genmab and SPG is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and SP Group AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SP Group AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with SP Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SP Group AS has no effect on the direction of Genmab AS i.e., Genmab AS and SP Group go up and down completely randomly.

Pair Corralation between Genmab AS and SP Group

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the SP Group. In addition to that, Genmab AS is 1.31 times more volatile than SP Group AS. It trades about -0.04 of its total potential returns per unit of risk. SP Group AS is currently generating about 0.02 per unit of volatility. If you would invest  30,750  in SP Group AS on December 29, 2024 and sell it today you would earn a total of  200.00  from holding SP Group AS or generate 0.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Genmab AS  vs.  SP Group AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
SP Group AS 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SP Group AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, SP Group is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Genmab AS and SP Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and SP Group

The main advantage of trading using opposite Genmab AS and SP Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, SP Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SP Group will offset losses from the drop in SP Group's long position.
The idea behind Genmab AS and SP Group AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities